Follow-Up – Fall 2018

Research doesn’t stop when we report it. Here is an update on a past UConn Health Journal stories:

Glycogen Storage Disease

Dr. Annabelle Rodriguez-Oquendo, professor of cell biology at the UConn School of Medicine, was recently issued a diagnostic patent to test for a genetic predisposition for an abnormal inflammatory response that causes several life-threatening disorders, like coronary artery disease and chronic inflammatory disease. Lipid Genomics, the start-up Rodriguez-Oquendo founded in 2010, has exclusively licensed the technology from UConn Health. The company is currently in discussion with potential investors to continue commercialization of this product, as well as other therapeutic innovations for HDL-cholesterol dysfunction.

Winter 2015, “Getting to the Heart of the Matter”

Related Articles

  • Together for the Kids

    UConn Health and Connecticut Children’s Medical Center join forces for the health of the state’s tiniest residence.

  • Trauma Director Puts Patients First

    Dr. Ryan Millea hasn’t lost focus on what drives him, whether responding at a moment’s notice to the surgical needs of a car accident victim or to an intensive care patient with a life-threatening gastrointestinal burst.

  • Sharing Knowledge for Better Patient Care

    Q&A with Dr. Leo J. Wolansky, Chair and Professor, UConn Radiology

  • Follow-Up – Fall 2018

    Research doesn’t stop once we report it. Read updates on past UConn Health Journal stories.